Rare Diseases are a Global Concern | CheckRare.com
Femida Gwady-Sridhar, PhD, talks her involvement with Rare Disease International (RDI).
Related Articles
Navigating Diagnosis and Treatment for Primary Biliary Cholangitis: The Integral Role of the Patient Voice
Dr. Sonal Kumar, discusses the integral role of the patient voice in navigating disease progression and determining an individualized care plan for people living with…
Neuroblastoma: Evan Foundation
Gavin Lindberg details his family’s experience with neuroblastoma, provides advice to families, and discusses the EVAN Foundation.
Tenosynovial Giant Cell Tumor (TGCT)
Tenosynovial giant cell tumor (TGCT) is a rare benign tumor involving the joint synovium, bursae, and tendon sheath.
Global Genes’ Patient and Advocate Initiatives
Daniel DeFabio, Global Genes and rare disease father, discusses Global Genes’ patient and advocate initiatives.
Ongoing Research for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
Sonia Gobeil, discusses their organization and ongoing research for autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).
PAH Clinical Research Highlights: CHEST 2024
Jean Elwing discusses PAH research leading to better management of people with Pulmonary Arterial Hypertension
Progressive Familial Intrahepatic Cholestasis (PFIC): Diagnosing, Treating, Monitoring
Drs. Patrick McKiernan and Nadia Ovchinsky discuss the recently published guidance on best practices to diagnose, treat, and monitor patients with progressive familial intrahepatic cholestasis…
Consider Rare: Suspecting and Diagnosing Fibrodysplasia Ossificans Progressiva (FOP)
This educational webinar on fibrodysplasia ossificans progressiva (FOP), hosted by Ellen Elias, MD and Christiaan Scott, MD, examines best practices to suspect and diagnose this…
Newborn Screening Update Following RFK’s Removal of Advisory Committee
Dean Suhr, President and co-founder of the MLD Foundation, discusses newborn screening updates and plans for gaining RUSP approval.
FcRn and Myasthenia Gravis
The role of neonatal fragment crystallizable receptor (FcRn) in myasthenia gravis (MG) and treatment options